Innovative Offering to the World of Textiles from DuPont Artistri

DuPont Imaging Technologies and Hyosung Corporation are presenting an innovative offering to the world of textiles, made possible by DuPont™ Artistri™ digital printing for textiles technology and the latest spandex technology from creora®.

Artistri™ will print on custom-designed swimwear and lingerie garments made from a variety of fabrics including a lightweight fabric using fine denier creora® spandex. The collaboration was driven by the trend for more decorative fabrics in lingerie and more sophisticated swimwear prints, along with the market need for quicker response and custom design in shorter runs.

“This cooperation was the perfect union of technology and fabric innovation and we are extremely excited with the results,” said Michael Lazzara, market development manager, DuPont™ Artistri™. “Artistri™ is the result of DuPont expertise in color science, digital ink development and long history of innovation in the synthetic fibers industry. DuPont is uniquely able to understand what it takes to create beautiful printing on fabric, which is evident in the fantastic printed fabrics resulting from the collaboration,” he said.

“We believe customers will be impressed with the quality and hand of the fabrics printed with Artistri™,” said Greg Vas Nunes, president of Hyosung, Europe and the Americas. “The combination of our innovation in creora® spandex in fabric and the Artistri™ acid dye ink provide outstanding wash fastness, durability and exceptional color penetration properties, making it ideal for the intimate apparel and swimwear markets.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.